Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eder

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Christian M Zechmann, Anna Malcher, et al.
Blood|January 29, 2021
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALLHanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, et al.
Annals of Nuclear Medicine|November 11, 2020
<sup>18</sup>F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphomaThorsten Derlin, Christian Schultze-Florey, Rudolf A Werner, et al.
Cell Metabolism|May 24, 2016
CRFR1 in AgRP Neurons Modulates Sympathetic Nervous System Activity to Adapt to Cold Stress and FastingYael Kuperman, Meira Weiss, Julien Dine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2017
PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate CancerAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Development of Novel PSMA Ligands for Imaging and Therapy with Copper IsotopesJosé Carlos Dos Santos, Barbro Beijer, Ulrike Bauder-Wüst, et al.
British Journal of Haematology|September 22, 2005
Expression of the p75 neurotrophin receptor in acute leukaemiaGernot Beutel, Johann Meyer, Liping Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsAli Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, et al.
Bone Marrow Transplantation|December 10, 2022
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipientsCatherina Lueck, Asterios Tzalavras, Philipp Wohlfarth, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Christian M Zechmann, Anna Malcher, et al.
Blood|January 29, 2021
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALLHanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, et al.
Annals of Nuclear Medicine|November 11, 2020
<sup>18</sup>F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphomaThorsten Derlin, Christian Schultze-Florey, Rudolf A Werner, et al.
Cell Metabolism|May 24, 2016
CRFR1 in AgRP Neurons Modulates Sympathetic Nervous System Activity to Adapt to Cold Stress and FastingYael Kuperman, Meira Weiss, Julien Dine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2017
PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate CancerAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Development of Novel PSMA Ligands for Imaging and Therapy with Copper IsotopesJosé Carlos Dos Santos, Barbro Beijer, Ulrike Bauder-Wüst, et al.
British Journal of Haematology|September 22, 2005
Expression of the p75 neurotrophin receptor in acute leukaemiaGernot Beutel, Johann Meyer, Liping Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsAli Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, et al.
Bone Marrow Transplantation|December 10, 2022
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipientsCatherina Lueck, Asterios Tzalavras, Philipp Wohlfarth, et al.
Pageof 29